Northstar Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Buy
5,210
+1,342
+35% +$117K 0.15% 85
2026
Q1
$330K Sell
3,868
-10,618
-73% -$946K 0.12% 96
2025
Q4
$1.14M Buy
+14,486
New +$1.14M 0.41% 58

Other funds holding CL

Northstar Advisory Group's CL Position: Q2 2026 in Review

Northstar Advisory Group increased its Colgate-Palmolive (CL) stake by 35% in Q2 2026, buying an estimated $117K and bringing the position to 5,210 shares worth $478K. The position accounts for 0.15% of the portfolio, ranked #85.

Northstar Advisory Group first reported a position in CL in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q4 2025. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Northstar Advisory Group held 5,210 shares of Colgate-Palmolive worth $478K as of Q2 2026.
  • Northstar Advisory Group bought 1,342 Colgate-Palmolive shares in Q2 2026, an estimated $117K.
  • Colgate-Palmolive made up 0.15% of Northstar Advisory Group's portfolio in Q2 2026, its #85 holding.
  • Northstar Advisory Group first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
  • Northstar Advisory Group's Colgate-Palmolive position peaked at $1.14M in Q4 2025.
  • 895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Northstar Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.